TITLE:
Systemic Form of Juvenile Idiopathic Arthritis: Epidemiological, Clinical, Paraclinical and Therapeutic Aspects of 13 Cases in Abidjan
AUTHORS:
Mohamed Diomandé, Abidou Kawélé Coulibaly, Astrid Nawé Ngandeu, Cyprien Kouakou, Ehaulier Soh Christian Louis Kouakou, Kouassi Jean Mermoz Djaha, Mariam Gbané-Koné, Baly Ouattara, Edmond Eti, Jean Claude Daboiko, Marcel N’zué Kouakou
KEYWORDS:
Systemic Idiopathic Juvenile Arthritis, Juvenile Idiopathic Arthritis, Profile, Children, Abidjan
JOURNAL NAME:
Open Journal of Rheumatology and Autoimmune Diseases,
Vol.7 No.2,
May
16,
2017
ABSTRACT: Objective: To describe the epidemiological, clinical,
paraclinical and therapeutic aspects of systemic juvenile idiopathic arthritis
observed in Abidjan. Materials and Method: This retrospective and descriptive study covered 13
children suffering from systemic juvenile idiopathic arthritis selected in the Rheumatology
Department of University Hospital Center of Cocody in Abidjan (Cote d’Ivoire)
from January 2005 to December 2015. We were interested to the sociodemographical,
clinical, paraclinical and therapeutic aspects. Results: The systemic form of the juvenile idiopathic
arthritis represented 0.2% of the 4608 rheumatologic diseases and 70.58% of the
JIA. We selected 6 boys and 7 girls, with an average age of 10.8 years and
mostly going to school (84.61%). The diagnostic delay was 18 months. The main
clinical signs were fever and joint damage observed each in 100% of cases,
impaired general condition (92.30%) and tumor syndrome (83.33%). Biological
signs were characterized by hyperleukocytosis (69.20%) and the presence of a
biologic inflammatory syndrome (on average, erythrocyte sedimentation rate 59.6 mm and C Reactive Protein
56.4 mg/l).
The cervical damage was the essential functional complication (38.46%). The
major treatment has been a therapeutic combination based on corticotherapy and
methotrexate (100%) with 1 death case by macrophage activation syndrome. Conclusion: Systemic juvenile idiopathic arthritis is rarely diagnosed in the
rheumatologic practice in Abidjan. It concerns children relatively big, and is characterized
by a febrile polyarthritis with impaired general condition and tumor syndrome.
This systemic form is treated by corticotherapy and methotrexate.